Home › Borstkanker › District of Columbia › Washington
Borstkanker klinische studies in Washington, DC
46 studies voor Borstkanker zoeken deelnemers op locaties in en rond Washington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
Genomic Services Research Program
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Older Breast Cancer Patients: Risk for Cognitive Decline
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Holy Cross Hospital ( Site 0073), Silver Spring · 7 mijl verwijderd
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mijl verwijderd
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
RekruterenFase 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · 6 mijl verwijderd
Identifying Patterns in the Breath of Individuals With Breast Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- en nog 1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
RekruterenFase 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RekruterenFase 1/2
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- en nog 5
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
RekruterenFase 2
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Rekruteren
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Rekruteren
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
RekruterenFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Rekruteren
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- en nog 2
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
RekruterenFase 2
- National Institute of Health Clinical Center, Bethesda · 7 mijl verwijderd
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekruterenFase 3
- American Oncology Partners, P.A., Bethesda · 7 mijl verwijderd
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · 7 mijl verwijderd
- Maryland Oncology Hematology P.A., Bethesda · 7 mijl verwijderd
- en nog 1
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- en nog 2
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
RekruterenFase 2
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
RekruterenFase 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Rekruteren
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- Holy Cross Hospital - Silver Spring, Silver Spring · 7 mijl verwijderd
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · 7 mijl verwijderd
Study in Patients With Breast Cancer Leptomeningeal Metastasis
RekruterenObservatieonderzoek
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mijl verwijderd
- Massive Bio SYNERGY-AI site, Bethesda · 7 mijl verwijderd
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Rekruteren
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
RekruterenGezonde vrijwilligers welkom
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- Maryland Oncology Hematology, PA, Silver Spring · 7 mijl verwijderd
- Maryland Oncology Hematology - Bethesda, Bethesda · 7 mijl verwijderd
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruterenObservatieonderzoek
- George Washington University, Washington D.C.
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Washington
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker55 studies
- Metastatische kanker43 studies
- Longkanker41 studies
- Prostaatkanker38 studies
- Obesitas33 studies
- Colorectale kanker29 studies
- Cardiovasculaire ziekte28 studies
- Blasenkanker26 studies
- Acute myeloïde leukemie24 studies
- Eierstokkanker23 studies
- Lymfoom23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.